Brain disorders cost Europe €800bn a year

BMJ 2011; 343 doi: http://dx.doi.org/10.1136/bmj.d6370 (Published 4 October 2011)
Cite this as: BMJ 2011;343:d6370

Get access to this article and all of bmj.com for the next 14 days

Sign up for a 14 day free trial today

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

  1. Ingrid Torjesen
  1. 1London

Europe spends more on brain disorders than on cardiovascular disease and cancer combined, a comprehensive study commissioned by the European Brain Council has found.

The study, published in European Neuropsychopharmacology (doi:10.1016/j.euroneuro.2011.08.008), found that Europe spends €798bn (£685bn; $1060bn) a year on neurological and psychiatric conditions, €192bn on cardiovascular disease, and €150-250bn on cancer. The total costs comprised direct costs, such as treatment, and indirect costs, such as the cost of sickness absence.

The most costly group of brain disorders was mood disorders, including major depression and bipolar disorders (€113bn a year) and dementia (€105bn).

The researchers, who came from across Europe, used existing prevalence and economic data to estimate the costs of 19 groups of brain disorders in 30 European countries …

Get access to this article and all of bmj.com for the next 14 days

Sign up for a 14 day free trial today

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

Article access

Article access for 1 day

Purchase this article for £20 $30 €32*

The PDF version can be downloaded as your personal record

* Prices do not include VAT

THIS WEEK'S POLL